"It's another kind of move made by Tether, it's not ordinary you know."
In order to become a majority shareholder, stablecoin-producing firm Tether recently hit the news regarding its $200 million investment into Blackrock Neurotech's Brain-Computer-Interface (BCI) technology platform.
The investment in Blackrock Neurotech is led by Tether Evo which is focused on creating a future where human capabilities and technology merge in ways that have never happened before.
Please note that Tether's investment in Blackrock Neurotech will fund the launch and commercialization of the firm's medical solutions that have already been successfully tested on more than 40 individuals.
Not only that, the investment will also increase Blackrock Neurotech's research and development efforts to ensure it remains a leading BCI technology firm over time.
In the long term, the firm intends to focus on human evolution and the improvement of the species by creating a bridge between the brain and artificial intelligence (AI) computing.
Founded in 2008, BlackRock Neurotech as a leader in the neuroscience, neuroengineering and neural prosthetics space has helped people affected by paralysis and neurological disorders that prevent them from seeing, hearing, feeling, walking or speaking.
That string, it allows disabled people to carry out important functions such as browsing the web, sending text messages and moving chairs with the power of their thoughts and it should be known that one of its patients in 2016 beat former US President Barack Obama using a BCI-controlled robotic arm.
